The Pennant Group (Nasdaq: PNTG) is poised for more acquisitions as the year progresses, supported by a pipeline of newly trained leaders for acquired assets. When considering transactions, the company seeks out often struggling companies in its existing or expanded markets that earn between $3 million and $10 million in revenue and sell at a multiple of 5x to 8x for hospice companies. “We have such a revolver, up to $250 million in the middle of last year, and we did an equity offering. As we closed out the year, we essentially had full access to the entire revolver and ample dry powder as we continue to grow,” CEO Brent Guerisoli said in a presentation at the Oppenheimer investor’s conference.
Read the full article: The Pennant Group Sees Less Competition for Hospice, Home Health Acquisition Targets //
Source: https://hospicenews.com/2025/03/18/the-pennant-group-sees-less-competition-for-hospice-home-health-acquisition-targets/